0.055MYR
52.65 MMYR
704.73 MMYR
844.02 M
About DUOPHARMA BIOTECH BERHAD
Sector
CEO
Leonard Ariff bin Abdul Shatar
Headquarters
Klang
Website
Founded
2000
ISIN
MYL7148OO009
FIGI
BBG000N9YML5
Duopharma Biotech Bhd. is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The firm offers consumer healthcare, classic pharmaceutical, and specialty pharmaceutical products. It operates through the Local and Export geographical segments. The company was founded in 2000 and is headquartered in Klang, Malaysia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DPHARMA is 1.160 MYR — it has decreased by 0.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MYX exchange DUOPHARMA BIOTECH BERHAD stocks are traded under the ticker DPHARMA.
DUOPHARMA BIOTECH BERHAD is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DUOPHARMA BIOTECH BERHAD has a max estimate of 1.500 MYR and a min estimate of 1.410 MYR.
DPHARMA earnings for the last quarter are 0.02 MYR whereas the estimation was 0.02 MYR which accounts for 0% surprise. Estimated earnings for the next quarter are 0.02 MYR. See more details about DUOPHARMA BIOTECH BERHAD earnings.
DUOPHARMA BIOTECH BERHAD revenue for the last quarter amounts to 177.10 M MYR despite the estimated figure of 177.00 M MYR. In the next quarter revenue is expected to reach 152.00 M MYR.
Yes, you can track DUOPHARMA BIOTECH BERHAD financials in yearly and quarterly reports right on TradingView.
Like other stocks, DPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DUOPHARMA BIOTECH BERHAD stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DUOPHARMA BIOTECH BERHAD EBITDA is 122.74 M MYR, and current EBITDA margin is 17.10%. See more stats in DUOPHARMA BIOTECH BERHAD financial statements.